How COVID-19 Affects Stakeholder Engagement & Value Communication

By Tom Hemy The COVID-19 pandemic has made the development and commercialization of pharmaceuticals and medical devices even more challenging. For example, in the value communication and stakeholder engagement area, many field representatives found themselves refused entry to hospitals and surgeries and unable to meet in-person with payers, doctors, and other key stakeholders. These meetings … Continued

2 of 2
Back to top
Powered by Translations.com GlobalLink OneLink Software